Czech pharma market grows by 4% in 2008
This article was originally published in Scrip
Executive Summary
Pharmaceutical sales in the Czech Republic grew by less than 4% to CK46 billion ($2 billion) at ex-manufacturer prices last year, says IMS. Cardiovasculars accounted for around 20% of the total, followed by anticancers. But total sales volume fell by almost 9% to 294 million packages.